EHA 2025: ADHD Treatment medication alleviate Fatigue in Patients with Malignant Diseases show Danish Study

Fatigue after cancer and cancer treatment is a significant burden for patients. At the same time, dealing with fatigue is an unmet need for patients. In this MEDtalk from EHA 2025, Professor Henrik Frederiksen from Odense University Hospital, Denmark, presented results from a Danish trial showing that methylphenidate, also known as Ritalin, which is used to treat ADHD, has a clinically meaningful effect in reducing fatigue scores and increasing active hours—with manageable side effects